![Tomas G. Neilan: Can large language models outperform ICD codes in detecting severe immune-related adverse events?](https://oncodaily.com/pub/uploads/2024/09/Tomas-G.-Neilan-e1725822739529.jpg)
Tomas G. Neilan: Can large language models outperform ICD codes in detecting severe immune-related adverse events?
Tomas G. Neilan, Director of the Cardio-Oncology Program at Massachusetts General Hospital, shared on X:
“Very proud of amazing Ginny Sun from MGH IM Residents. Co-led with Kerry Reynolds from Mass General Cancer Center. Large language models with an excellent sensitivity and specificity for several key ICI associated adverse events and in 9 secs. Journal of Clinical Oncology.
Authors: Virginia H. Sun, Julius C. Heemelaar, Ibrahim Hadzic, Vineet K. Raghu, Chia-Yun Wu, Leyre Zubiri, Azin Ghamari, Nicole R. LeBoeuf, Osama Abu-Shawer, Kenneth L. Kehl, Shilpa Grover, Prabhsimranjot Singh, Giselle A. Suero-Abreu, Jessica Wu, Ayo S. Falade, Kelley Grealish, Molly F. Thomas, Nora Hathaway, Benjamin D. Medoff, Hannah K. Gilman, Alexandra-Chloe Villani, Jor Sam Ho, Meghan J. Mooradian, Meghan E. Sise, Daniel A. Zlotoff, Steven M. Blum, Michael Dougan, Ryan J. Sullivan, Tomas G. Neilan, and Kerry L. Reynolds. ”
Source: Tomas G. Neilan/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023